APA (7th ed.) Citation

AP, A., M, O., AI, D., RS, L., JM, M., TG, T., . . . A, R. (2020). Continuous versus intermittent BRAF and MEK inhibition in patients with BRAF-mutated melanoma: A randomized phase 2 trial. Nature medicine, 26(10), 1564. https://doi.org/10.1038/s41591-020-1060-8

Chicago Style (17th ed.) Citation

AP, Algazi, et al. "Continuous Versus Intermittent BRAF and MEK Inhibition in Patients with BRAF-mutated Melanoma: A Randomized Phase 2 Trial." Nature Medicine 26, no. 10 (2020): 1564. https://doi.org/10.1038/s41591-020-1060-8.

MLA (9th ed.) Citation

AP, Algazi, et al. "Continuous Versus Intermittent BRAF and MEK Inhibition in Patients with BRAF-mutated Melanoma: A Randomized Phase 2 Trial." Nature Medicine, vol. 26, no. 10, 2020, p. 1564, https://doi.org/10.1038/s41591-020-1060-8.